Otsuka Holdings
4578.T
#629
Rank
โ‚น3.729 T
Marketcap
โ‚น7,118
Share price
0.13%
Change (1 day)
50.88%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

EPS for Otsuka Holdings (4578.T)

EPS in 2023 (TTM): โ‚น200.19

According to Otsuka Holdings 's latest financial reports the company's current EPS (TTM) is โ‚น330.84. In 2022 the company made an earnings per share (EPS) of โ‚น171.79 a decrease over its 2021 EPS that were of โ‚น196.06.

EPS history for Otsuka Holdings from 2010 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น200.1916.53%
2022โ‚น171.79-12.38%
2021โ‚น196.06-18.58%
2020โ‚น240.8018.81%
2019โ‚น202.6855.85%
2018โ‚น130.05-25.05%
2017โ‚น173.5110.15%
2016โ‚น157.537.74%
2015โ‚น146.20-39.2%
2014โ‚น240.46-20.14%
2013โ‚น301.1151.58%
2012โ‚น198.65-6.65%
2011โ‚น212.8029.28%
2010โ‚น164.61